Thermo Fisher Scientific Inc.

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2024-12-06 pm EST 5-day change 1st Jan Change
529.36 USD +1.63% Intraday chart for Thermo Fisher Scientific Inc. -0.05% -0.27%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Thermo Fisher Scientific Insider Sold Shares Worth $10,624,559, According to a Recent SEC Filing Dec. 04 MT
Thermo Fisher Scientific Launches CTS? Detachable Dynabeads? CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production Dec. 04 CI
Nephron Research Trims Price Target on Thermo Fisher Scientific to $650 From $675 Dec. 02 MT
CMB International Initiates Thermo Fisher Scientific at Buy With $670 Price Target Nov. 21 MT
Thermo Fisher Scientific Inc. Presents at 6th Annual Wolfe Research Healthcare Conference 2024, Nov-19-2024 08:00 AM Nov. 19
Thermo Fisher Scientific Authorizes $4 Billion Share Buyback Nov. 15 MT
Thermo Fisher Board Approves New $4 Billion Stock Buyback Nov. 15 DJ
Tranche Update on Thermo Fisher Scientific Inc.'s Equity Buyback Plan announced on November 14, 2023. Nov. 15 CI
Thermo Fisher Scientific Inc. announces an Equity Buyback for $4,000 million worth of its shares. Nov. 15 CI
Thermo Fisher Scientific Inc.'s Equity Buyback announced on November 14, 2023, has expired with 5,523,139 shares, representing 1.43% for $3,000 million. Nov. 14 CI
Thermo Fisher Scientific Inc. authorizes a Buyback Plan. Nov. 14 CI
Mainz Biomed, Thermo Fisher Partner to Develop Colorectal Cancer Screening Test Nov. 12 MT
Mainz Biomed N.V. and Thermo Fisher Scientific Inc. Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets Nov. 12 CI
Quidelortho Corporation Announces Executive Changes Nov. 08 CI
Seer Enters into A Co-Marketing and Sales Agreement with Thermo Fisher Scientific Nov. 06 CI
Tranche Update on Thermo Fisher Scientific Inc.'s Equity Buyback Plan announced on November 14, 2023. Nov. 01 CI
Thermo Fisher Scientific Insider Sold Shares Worth $11,049,123, According to a Recent SEC Filing Oct. 30 MT
Thermo Fisher Scientific Insider Sold Shares Worth $1,120,320, According to a Recent SEC Filing Oct. 29 MT
Devyser Enters Collaboration to Secure US Approval for Kidney Transplant Monitoring Test Oct. 29 MT
Devyser aims to secure FDA approval for monitoring product Oct. 29 FW
Devyser Enters into Agreement with Thermo Fisher Scientific to Collaborate on Obtaining U.S. Food and Drug Administration Approval for One Lambda? Devyser Accept Cfdna Oct. 29 CI
ARC Independent Upgrades Thermo Fisher Scientific to Buy From Hold, $620 Price Target Oct. 28 MT
Stephens Adjusts Price Target on Thermo Fisher Scientific to $670 From $680, Maintains Overweight Rating Oct. 25 MT
Redburn Atlantic Adjusts Price Target on Thermo Fisher Scientific to $645 From $680 Oct. 25 MT
Morgan Stanley Adjusts Price Target on Thermo Fisher Scientific to $670 From $680, Maintains Overweight Rating Oct. 24 MT
Chart Thermo Fisher Scientific Inc.
TMO: Dynamic Chart
Logo Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Employees
122,000
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
surperformance-ratings-light-chart THERMO-FISHER-SCIENTIFIC-More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
529.36USD
Average target price
653.94USD
Spread / Average Target
+23.53%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. TMO Stock
  4. News Thermo Fisher Scientific Inc.
  5. ARC Independent Upgrades Thermo Fisher Scientific to Buy From Hold, $620 Price Target